首页> 美国卫生研究院文献>Biomicrofluidics >Flow reproducibility of whole blood and other bodily fluids in simplified no reaction lateral flow assay devices
【2h】

Flow reproducibility of whole blood and other bodily fluids in simplified no reaction lateral flow assay devices

机译:简化的无反应侧流测定装置中全血和其他体液的流量重现性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The “no reaction” lateral flow assay (nrLFA) uses a simplified LFA structure with no conjugate pad and no stored reagents. In the nrLFA, the capillary-based transport time or distance is the key indicator, rather than the outcome of a biochemical reaction. Hence, the calibration and reproducibility of the nrLFA device are critical. The capillary flow properties of several membrane types (nitrocellulose, nylon, cellulose acetate, polyethersulfone, and polyvinylidene difluoride) are evaluated. Flow rate evaluations of MilliporeSigma Hi-Flow™ Plus (HF075, HF135 and HF180) nitrocellulose membranes on nrLFA are performed using bodily fluids (whole blood, blood plasma, and artificial sweat). The results demonstrate that fluids with lower viscosity travel faster, and membranes with slower flow rate exhibit higher capability to distinguish fluids with different viscosities. Reproducibility tests of nrLFA are performed on HF075, demonstrating excellent reproducibility. The coefficient of variation for blood coagulation tests performed with the nrLFA using induced coagulation was 5% for the plasma front and 2% for the RBC front. The effects of variation in blood hematocrit and sample volume are also reported. The overall results indicate that the nrLFA approach has a high potential to be commercially developed as a blood monitoring point-of-care device with simple calibration capability and excellent reproducibility.
机译:“无反应”侧向流动测定法(nrLFA)使用简化的LFA结构,没有共轭垫,也没有存储试剂。在nrLFA中,基于毛细管的转运时间或距离是关键指标,而不是生化反应的结果。因此,nrLFA设备的校准和再现性至关重要。评估了几种膜类型(硝酸纤维素,尼龙,醋酸纤维素,聚醚砜和聚偏二氟乙烯)的毛细流动特性。使用体液(全血,血浆和人工汗液)对nrLFA上的MilliporeSigma Hi-Flow™Plus(HF075,HF135和HF180)硝酸纤维素膜进行流速评估。结果表明,粘度较低的流体流动更快,而流速较慢的膜则具有较高的分辨不同粘度流体的能力。 nrLFA的再现性测试是在HF075上进行的,证明了其出色的再现性。使用诱导凝血的nrLFA进行的血液凝结试验的变异系数,血浆前沿为5%,RBC前沿为2%。还报告了血细胞比容和样本量变化的影响。总体结果表明,nrLFA方法具有很强的潜力,可作为具有简单校准功能和出色重现性的血液监测医疗现场设备进行商业开发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号